Endo wins over Auxilium, QLT dropped
This article was originally published in Scrip
Executive Summary
Endo is to acquire Auxilium Pharmaceuticals in a deal worth $2.6bn, just weeks after Auxilium's board unanimously rejected a previous $2.2bn offer (scripintelligence.com, 23 September 2014).